Other studies have found PLA2R in hepatitis B virus, generalized lupus erythematosus, and malignant neoplasm lowering its specificity [13]; however, the method used was Western blotting, which has a higher sensibility than ELISA augmenting the rate of false positive. Here, PLA2R1 is linked to cancer.